These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Twelve-month outcome in bipolar patients with and without personality disorders. Dunayevich E; Sax KW; Keck PE; McElroy SL; Sorter MT; McConville BJ; Strakowski SM J Clin Psychiatry; 2000 Feb; 61(2):134-9. PubMed ID: 10732661 [TBL] [Abstract][Full Text] [Related]
26. [Pharmacological treatment of psychiatric emergencies in general practice (author's transl)]. Wildbolz A Schweiz Rundsch Med Prax; 1981 Feb; 70(6):211-4. PubMed ID: 7243742 [No Abstract] [Full Text] [Related]
27. [Neuropsychological evaluation of a case of organic personality disorder due to penetrating brain injury]. Sanz de la Torre JC; Pérez-Ríos M Rev Neurol; 1996 Jun; 24(130):643-9. PubMed ID: 8653607 [TBL] [Abstract][Full Text] [Related]
28. [Biographic features and personality patterns in patients with chronic ulcerative colitis (author's transl)]. Kipnowski J; Kipnowski A Psychother Psychosom Med Psychol; 1982 Mar; 32(2):31-4. PubMed ID: 7111623 [No Abstract] [Full Text] [Related]
29. Comorbid personality disorder and treatment use in a community sample of youths: a 20-year follow-up. Kasen S; Cohen P; Skodol AE; First MB; Johnson JG; Brook JS; Oldham JM Acta Psychiatr Scand; 2007 Jan; 115(1):56-65. PubMed ID: 17201867 [TBL] [Abstract][Full Text] [Related]
30. [Narcissism--variable of personality and personality disorder]. Ritter K; Lammers CH Psychother Psychosom Med Psychol; 2007 Feb; 57(2):53-60. PubMed ID: 17211773 [TBL] [Abstract][Full Text] [Related]
32. [Problems of modern psychopharmacology]. Kapor G Neuropsihijatrija; 1964; 12(1-4):19-25. PubMed ID: 16305151 [No Abstract] [Full Text] [Related]
33. Elements of dynamics II: psychodynamic prescribing. Forrest DV J Am Acad Psychoanal Dyn Psychiatry; 2004; 32(2):359-80. PubMed ID: 15274501 [TBL] [Abstract][Full Text] [Related]
34. The importance of personal medicine: a qualitative study of resilience in people with psychiatric disabilities. Deegan PE Scand J Public Health Suppl; 2005 Oct; 66():29-35. PubMed ID: 16214720 [TBL] [Abstract][Full Text] [Related]
37. [Ethics in psychopharmaceutical research]. Knezević A Med Pregl; 1996; 49(3-4):103-4. PubMed ID: 8692077 [TBL] [Abstract][Full Text] [Related]
38. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological treatment. Lara DR; Akiskal HS J Affect Disord; 2006 Aug; 94(1-3):89-103. PubMed ID: 16712943 [TBL] [Abstract][Full Text] [Related]
39. [Some aspects of pharmacotherapy in the context of transference-countertransference]. Jakubczyk A; Murawiec S; Zechowski C Psychiatr Pol; 2004; 38(6):1115-25. PubMed ID: 15779675 [TBL] [Abstract][Full Text] [Related]
40. Assessment and management of dangerous and severe personality disorders. Völlm B Curr Opin Psychiatry; 2009 Sep; 22(5):501-6. PubMed ID: 19424066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]